-
effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
June 01, 2013 - developed for
technologies and programs that appear to be close to diffusion into practice in the United States … or for which some preliminary efficacy data in the target population are available) in
the United States
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_disposition-comments.pdf
May 29, 2013 - Disposition of Comments Report for Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations
Comparative Effectiveness Research Review Disposition of Comments Report
Research Review Title: Pharmacologic and Mechanical Prophylaxis of Venous
Thromboembolism Among Special P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
December 30, 2015 - Correct, AHRQ reviews focus on interventions
currently available in the United States and our results … We included any drug available in the United States if
there were eligible trials. … It appears (although is not
explicitly states, that I can find) that only subjective,
patientreported … It appears
(although is not explicitly states, that I can find) that only
subjective, patient reported … It appears
(although is not explicitly states, that I can find) that only
subjective, patient-reported
-
effectivehealthcare.ahrq.gov/sites/default/files/pregnancy_hi_impact.pdf
January 01, 2012 - developed for
technologies and programs that appear to be closer to diffusion into practice in the United States … with some preliminary efficacy data on
the target population for devices and programs) in the United States … stimulates behaviors to seek out
medical care that addresses conditions early (e.g., pre-diabetic states … late 2011,
51
and now
LifeCodexx is not expected to compete with a Trisomy 21 test in the United States … Sequenom states that circulating fetal
DNA can be obtained from a maternal blood sample very early